Alnylam trades partner Sanofi for Regeneron in $800M deal
April 08, 2019 at 09:10 AM EDT
Cambridge gene therapy firm Alnylam is changing alliances, cutting research ties with longtime partner Sanofi and teaming up with Regeneron on new eye and central nervous system treatments.